Clinical Trials Browser

Phase 2/3 × Stomach Neoplasms × Gastrointestinal × Clear all

NCT07221149 2026-03-04

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Phase 2/3 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT07392892 2026-02-06

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Phase 2/3 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT07241715 2025-11-21

CONVERGENCE

Phase 2/3 Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT07219238 2025-10-21

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Phase 2/3 Not yet recruiting

GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05980481 2025-09-29

A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer

Phase 2/3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT06826079 2025-09-09

SNCCTGC

Phase 2/3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT05002127 2025-08-07

A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

Phase 2/3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT04082364 2025-06-08

MAHOGANY

Phase 2/3 Completed

82 enrolled 22 charts

Gastrointestinal

Stomach Neoplasms

NCT07000253 2025-06-02

OMEC-5

Phase 2/3 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06977061 2025-05-16

Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression

Phase 2/3 Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT06028737 2025-05-06

OCTASUR

Phase 2/3 Recruiting

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms

NCT01924819 2025-03-04

TOPGEAR

Phase 2/3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT06782412 2025-02-07

FAPIDO

Phase 2/3 Recruiting

Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT02746796 2024-05-03

Study of ONO-4538 in Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT06221748 2024-04-03

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

Phase 2/3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT05427383 2023-12-19

KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy

Phase 2/3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT03607656 2023-12-18

CHANGE

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT05325528 2023-02-01

Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT05300945 2022-12-06

HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy

Phase 2/3 Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT02661971 2022-07-11

RAMSES/FLOT7

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT03130790 2022-02-15

Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT05002686 2021-08-24

Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT04393584 2021-04-13

RusGCG-01

Phase 2/3 Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms

NCT04677673 2020-12-21

RJGC-Senile

Phase 2/3 Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT02581462 2020-08-11

PETRARCA

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT01516944 2020-02-13

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT01216644 2019-06-19

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Pathologic Complete Response, Stomach Neoplasms

NCT01683864 2018-01-30

HIPECStomach

Phase 2/3 Terminated

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT03399253 2018-01-16

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02461407 2017-12-29

Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02509806 2017-10-09

Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02510469 2017-10-09

Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT01641939 2017-05-12

A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Phase 2/3 Terminated

415 enrolled 25 charts

Gastrointestinal

Stomach Neoplasms

NCT02817425 2016-06-29

A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02409199 2015-11-18

A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02413476 2015-05-19

Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02442362 2015-05-13

TOF Versus SOX in Metastatic Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT02423278 2015-04-22

The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT00332280 2013-03-20

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Phase 2/3 Terminated

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT01787539 2013-02-08

STOPEROPCHEM

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT01655641 2012-10-16

TMGS

Phase 2/3 Unknown

Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT01528059 2012-02-07

Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes

Phase 2/3 Unknown

Gastrointestinal

Diabetes Mellitus, Diabetes Mellitus, Type 2, Stomach Neoplasms

NCT00970138 2011-07-12

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT00639327 2011-06-28

Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT01206218 2010-09-21

BREC-AGC

Phase 2/3 Unknown

Gastrointestinal

Stomach Neoplasms

NCT00359476 2010-03-02

A Study of Vinflunine in Patients With Gastric Cancer

Phase 2/3 Terminated

Gastrointestinal

Stomach Neoplasms

NCT00290966 2009-04-29

Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms

NCT00503321 2009-01-23

eNCIT-Japan

Phase 2/3 Terminated

Gastrointestinal

Stomach Neoplasms